Transplant Biomedicals is a European company based in Barcelona aimed at developing novel medical strategies to improve organ, tissue and cellular preservation to overall enhance patients´ wellness.


  • Area of Activity
  • Venture capital
  • Transplant
  • Technology transfer
  • Cellular Therapy
  • Tissue therapy
  • Maintenance cell cultures
  • Private investor
  • Internet and information technologies
  • Healthcare facilities and services
  • Hospitals
  • Manufacture and commercialization of cell lines
  • Medical and surgical equipment
  • Medical Devices
  • Biotechnology kits
  • Cell culture
  • Cellular and molecular biology
  • Company type
  • Investors - Venture Capital
  • Health Biotechnology
  • Services and consulting for biotech sector
  • Technology Services
  • Public and Private Organizations - Non Profit Centers - Medical Research Facilities
  • Industrial Biotechnology - Manufacturers
Headquarter
Barcelona Advanced Industry Park, Marie Curie 8-14,
Barcelona, Barcelona 08042 , ES
P: +34 935 27 27 20
E:info@transplantbiomed.com

“At Transplant Biomedicals team we are excited to solve the most ambitious challenges of health professionals and, therefore, we transform scientific and technological knowledge into products that contribute to the improvement of people’s health.” - Joan Salgado – Chief Executive Officer

TEAM
Joan Salgado, PhD - Chief Executive Officer
Dr. Carmen Peralta - Chief Scientific Officer
Miguel Ángel Gómez - Chief Technology Officer
Jordi Petit, MBA - Chief Financial Officer
Montse Gutiérrez - QA&RA Manager
Diana Villanueva - Clinical Operations Manager

BOARD OF DIERECTORS
Joaquin Sanz Berrioategortua
Giacomo de Simone
Dra. Carmen Peralta

ADVISORY BOARD
Dr. Silvina Ramella
Dr. Blanca Miranda
Dr. Enrique Castellón
Sr. Raj Airey

Transplant Biomedicals is developing a new organ transport device available for hospital use. The device uses a revolutionary technology leading to superior preservation of the organs during transport from the donor hospital to the transplant center.

Our high quality and convenient product aims to become the global gold standard for transplant centers by reducing the risk of delayed graft function, improving graft survival and as such leading to better patient outcomes. In addition, our product has the potential to use part of the marginal organs that are currently discarded and thus reduce the waiting lists. [3D conceptual model]

Our values are at the basis of all our organizations actions

  • Fight for our cause, the patient
  • Trust and commitment
  • Innovation, entrepreneurship, creativity and passion
  • Superior quality that meets needs and provides sustainable added value

INVESTORS
Transplant Biomedicals is backed by specialized national venture capital. These investors include Caixa Capital Risc and Kereon Partners and several private investors. To date, Transplant Biomedicals has raised over €4M.

Transplant Biomedicals